Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies
Although numerous mouse models of B-cell malignancy have been developed via the enforced expression of defined oncogenic lesions, the feasibility of generating lineage-defined human B-cell malignancies using mice reconstituted with modified human hematopoietic stem cells (HSCs) remains unclear. In f...
Main Authors: | Schweighofer, C. D., Abruzzo, L., Frenzel, Lukas P., Wendtner, C. M., Leskov, Ilya B., Pallasch, Christian, Drake, Adam, Iliopoulou, Bettina P., Souza, A., Shen, C.-H., Hemann, Michael, Chen, Jianzhu |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2014
|
Online Access: | http://hdl.handle.net/1721.1/85587 https://orcid.org/0000-0002-5687-6154 |
Similar Items
-
Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
by: Pallasch, Christian, et al.
Published: (2015) -
Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
by: Ahmad, Aliza, et al.
Published: (2022) -
Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) Mice
by: Drake, Adam, et al.
Published: (2011) -
Interleukins 7 and 15 Maintain Human T Cell Proliferative Capacity through STAT5 Signaling
by: Drake, Adam, et al.
Published: (2017) -
The pattern of CD15, CD30 and Bcl-2 expression in diffuse large B-cell lymphoma
by: Eow, G.I., et al.
Published: (2006)